Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 2/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | MAT2A | P31153 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 3/20 | 0.39 |
| ▸ | HTR7 | P34969 | 3/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
| ▸ | VNN1 | O95497 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15743854 | 0.88 | HCRTR1 (0.41) | HCRTR1CYP1A2 | |
| SCHEMBL14664083 | 0.85 | HCRTR1 (0.40) | HCRTR1CYP1A2 | |
| SCHEMBL4916897 | 0.81 | HCRTR1 (0.52) | NPC1RAB9ASPHK2SPHK1PDK2 | |
| SCHEMBL4916902 | 0.81 | HCRTR1 (0.52) | NPC1RAB9ASPHK2SPHK1PDK2 | |
| SCHEMBL18887525 | 0.80 | TRPV1 (0.47) | NPC1RAB9ACYP1A2 | |
| SCHEMBL27896426 | 0.79 | HCRTR1 (0.40) | RAB9ADPP4HCRTR1CYP1A2 | |
| SCHEMBL2194984 | 0.78 | TRPV1 (0.47) | HCRTR1CYP1A2 | |
| SCHEMBL14648172 | 0.77 | TRPV1 (0.46) | HCRTR1 | |
| SCHEMBL13570373 | 0.74 | SCN9A (0.58) | NPC1RAB9ASPHK2SPHK1PDK2 | |
| SCHEMBL14647964 | 0.74 | TRPV1 (0.47) | HCRTR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2519506-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2012-11-07 | — | — | EP | claimed |